Lind Global Fund II LP 13D and 13G filings for Aridis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 8:02 pm Sale | 2023-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Lind Global Fund II LP | 0 0.000% | -3,000,000 (Position Closed) | Filing |
| 2023-03-20 4:35 pm Purchase | 2023-03-16 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Lind Global Fund II LP | 3,000,000 8.300% | 3,000,000 (New Position) | Filing |